Samrat Pharmachem Ltd. | Small-cap | Basic Materials
₹322.45
-0.26%
| Samrat Pharmachem Stock Comparison:
Samrat Pharmachem vs Navin FluorineSamrat Pharmachem vs Deepak NitriteSamrat Pharmachem vs India GlycolsSamrat Pharmachem vs Styrenix PerformanceSamrat Pharmachem vs Gujarat AlkaliesSamrat Pharmachem vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 712.0M
Gross Profit 24.2M 3.39%
Operating Income -346.0K -0.05%
Net Income -4.0M -0.56%

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 496.9M
Shareholders Equity 718.0M
Debt to Equity 0.69

Cash Flow Metrics

Revenue & Profitability Trend

Samrat Pharmachem Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i2.9B2.8B3.1B2.2B1.8B
Cost of Goods Sold i2.7B2.7B2.8B1.9B1.7B
Gross Profit i191.1M76.8M287.7M280.8M118.7M
Gross Margin % i6.7%2.7%9.3%12.7%6.6%
Operating Expenses
Research & Development i-30.0K0--
Selling, General & Administrative i-18.4M18.8M12.1M11.8M
Other Operating Expenses i66.5M11.3M10.2M8.0M1.0M
Total Operating Expenses i66.5M29.7M29.0M20.1M12.8M
Operating Income i95.9M18.7M233.9M237.8M87.4M
Operating Margin % i3.4%0.7%7.5%10.7%4.9%
Non-Operating Items
Interest Income i-2.8M1.8M1.4M864.0K
Interest Expense i6.7M5.5M9.3M3.6M9.4M
Other Non-Operating Income-----
Pre-tax Income i98.9M25.2M225.3M236.0M73.4M
Income Tax i27.7M3.6M59.0M64.2M20.1M
Effective Tax Rate % i28.1%14.2%26.2%27.2%27.4%
Net Income i71.1M21.6M166.3M171.8M53.3M
Net Margin % i2.5%0.8%5.4%7.7%3.0%
Key Metrics
EBITDA i112.1M27.1M240.8M245.5M90.2M
EPS (Basic) i-₹7.00₹53.83₹55.62₹17.26
EPS (Diluted) i-₹7.00₹53.83₹55.62₹17.26
Basic Shares Outstanding i-3089700308970030897003089700
Diluted Shares Outstanding i-3089700308970030897003089700

Income Statement Trend

Samrat Pharmachem Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i483.0K96.7M118.6M147.0M25.1M
Short-term Investments i4.9M109.0K139.0K100.0K10.0K
Accounts Receivable i565.4M692.8M516.7M435.7M330.1M
Inventory i380.1M206.8M325.3M124.2M114.0M
Other Current Assets82.8M49.0K50.0K200.0K367.0K
Total Current Assets i1.0B1.0B990.5M712.6M473.2M
Non-Current Assets
Property, Plant & Equipment i-0107.0M99.8M93.9M
Goodwill i146.0K66.0K75.0K85.0K95.0K
Intangible Assets i146.0K66.0K75.0K85.0K95.0K
Long-term Investments-----
Other Non-Current Assets-6.1M497.0K1.0K-3.0K
Total Non-Current Assets i181.3M191.7M175.4M133.5M100.7M
Total Assets i1.2B1.2B1.2B846.1M574.0M
Liabilities
Current Liabilities
Accounts Payable i385.6M476.7M318.8M233.9M176.6M
Short-term Debt i99.1M84.5M186.6M75.2M87.9M
Current Portion of Long-term Debt-----
Other Current Liabilities22.0K-6.0K493.0K8.9M1.7M
Total Current Liabilities i495.8M564.0M531.9M373.3M273.3M
Non-Current Liabilities
Long-term Debt i00000
Deferred Tax Liabilities i1.1M3.4M2.5M4.6M4.3M
Other Non-Current Liabilities-6.0K---1.0K
Total Non-Current Liabilities i1.1M3.4M2.5M4.6M4.3M
Total Liabilities i496.9M567.4M534.5M377.9M277.6M
Equity
Common Stock i30.9M30.9M30.9M30.9M30.9M
Retained Earnings i-619.1M600.5M437.3M265.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i718.0M650.0M631.4M468.2M296.4M
Key Metrics
Total Debt i99.1M84.5M186.6M75.2M87.9M
Working Capital i537.8M461.7M458.6M339.3M200.0M

Balance Sheet Composition

Samrat Pharmachem Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i98.9M25.2M225.3M236.0M73.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-100.9M-65.1M-326.1M-115.1M34.4M
Operating Cash Flow i1.3M-35.9M-90.3M126.4M119.7M
Investing Activities
Capital Expenditures i-5.1M-6.5M-13.6M-12.0M-16.5M
Acquisitions i-----
Investment Purchases i-417.5M-305.3M-85.2M-85.2M-
Investment Sales i418.8M304.7M66.8M85.2M-
Investing Cash Flow i-3.7M-7.1M-32.0M-12.0M-16.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-3.1M-3.1M-3.1M--
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i11.5M-105.1M108.3M-12.7M-3.0M
Free Cash Flow i-106.0M87.5M-109.0M162.0M20.7M
Net Change in Cash i9.0M-148.1M-14.0M101.7M100.2M

Cash Flow Trend

Samrat Pharmachem Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.81
Price to Book 1.37
Price to Sales 0.35

Profitability Ratios

Profit Margin 1.72%
Operating Margin -0.06%
Return on Equity 9.91%
Return on Assets 5.85%

Financial Health

Current Ratio 2.08
Debt to Equity 13.81
Beta -0.32

Per Share Data

EPS (TTM) ₹23.02
Book Value per Share ₹232.02
Revenue per Share ₹908.08

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
samratph982.4M13.811.379.91%1.72%13.81
Navin Fluorine 255.9B69.939.4410.99%13.90%55.85
Deepak Nitrite 246.9B40.634.5811.85%7.58%23.36
India Glycols 50.0B20.492.2110.24%6.35%83.85
Styrenix Performance 46.4B20.533.9720.14%7.00%34.02
Gujarat Alkalies 40.4B70.120.67-1.08%-0.82%9.30

Financial data is updated regularly. All figures are in the company's reporting currency.